Form 4: Pacira CFO Sells Shares for Tax Obligations

Pacira BioSciences' Chief Financial Officer, Shawn Cross, disposed of 6,690 shares of common stock to cover tax obligations upon the vesting of restricted stock units.

Summary

• Shawn Cross, Chief Financial Officer of Pacira BioSciences, Inc. (PCRX), reported a transaction on October 31, 2025.
• The transaction involved the disposition of 6,690 shares of common stock.
• These shares were withheld by the issuer to cover tax obligations associated with the vesting of restricted stock units.
• The price per share for the disposition was $21.38.
• Following this transaction, Shawn Cross beneficially owns 68,310 shares of Pacira BioSciences common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction (shares withheld for tax obligations upon RSU vesting) by an insider, which is neutral in sentiment and does not indicate any positive or negative operational or financial developments for the company.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary transaction by an executive to cover tax obligations related to vested restricted stock units.

Key Dates

Recommendation

This Form 4 reports a routine, tax-related disposition of shares by an insider upon RSU vesting. Such transactions are common and typically do not reflect a change in management's outlook on the company's future performance or fundamental value. Therefore, it does not provide a basis for altering an existing investment thesis or recommendation.

Keywords

Pacira BioSciences, PCRX, Shawn Cross, Form 4, insider transaction, stock disposition, restricted stock units, tax withholding, CFO